OTC Markets OTCPK - Delayed Quote USD
TC Biopharm (Holdings) Plc (TCBPY)
0.3000
-0.0268
(-8.20%)
At close: May 9 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Bryan Leland Kobel | CEO & Director | 544.56k | -- | 1979 |
| Mr. Martin Edward Thorp | CFO & Director | 410.52k | -- | 1952 |
| Mr. Christopher Camarra | Executive Vice President of Communications | -- | -- | -- |
| Dr. Lauren Bor Ph.D. | Head of Commercial Development Division | -- | -- | -- |
TC Biopharm (Holdings) Plc
Maxim 1
2 Parklands Way Holytown
Motherwell, ML1 4WR
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
Description
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Corporate Governance
TC Biopharm (Holdings) Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 30, 2025 at 12:00 AM UTC
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Related Tickers
DRMA Dermata Therapeutics, Inc.
0.8103
+0.04%
NLSP NLS Pharmaceutics AG
1.6400
-3.53%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2800
-2.29%
VRPX Virpax Pharmaceuticals, Inc.
0.2382
-2.78%
WINT Windtree Therapeutics, Inc.
0.8522
+0.39%
CELZ Creative Medical Technology Holdings, Inc.
2.1400
+2.88%
PXMD PaxMedica, Inc.
0.0001
0.00%
VRAX Virax Biolabs Group Limited
1.0500
-0.94%
TENX Tenax Therapeutics, Inc.
5.57
-2.02%
XCUR Exicure, Inc.
11.44
+0.79%